Xencor (XNCR) Revenue (2013 - 2026)
Xencor's (XNCR) quarterly Revenue came in at $4.5 million in Q1 2026, down 86.2% year-on-year from $32.7 million in Q1 2025, and down 84.01% on a QoQ basis from $28.2 million in Q4 2025.
Xencor (XNCR) Revenue (2013 - 2026) Analysis & Trends
Xencor (XNCR) has 14 years of Revenue data on file, last reported at $4.5 million in Q1 2026.
- On a quarterly basis, Revenue fell 86.2% year-over-year to $4.5 million in Q1 2026; TTM through Mar 2026 was $97.4 million, a 23.48% decrease from a year earlier, with the FY2025 full-year figure at $125.6 million, up 13.65% from the prior year.
- Revenue for Q1 2026 stood at $4.5 million, down from $28.2 million in the prior quarter.
- Over the last five years, Revenue for XNCR reached as high as $85.5 million in Q1 2022 and fell as low as $4.5 million in Q1 2026.
- Historically, Revenue has averaged $34.1 million across 5 years, with a median of $28.2 million in 2025.
- Across the five-year window, Revenue surged 151.46% in 2022 and tumbled 86.2% in 2026, its largest moves.
- Year by year, Revenue stood at $21.6 million in 2022, then soared by 136.07% to $51.0 million in 2023, then rose by 3.49% to $52.8 million in 2024, then tumbled by 46.51% to $28.2 million in 2025, then sank by 84.01% to $4.5 million in 2026.
- Per Business Quant data, the three most recent Revenue figures were $4.5 million in Q1 2026, $28.2 million in Q4 2025, and $21.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.51 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.99 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 3.61 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 1.30 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Xencor | 1.47 Bn | 1.09 Bn | - | 4.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.52 Mn |
| Dec 31, 2025 | 28.24 Mn |
| Sep 30, 2025 | 21.00 Mn |
| Jun 30, 2025 | 43.61 Mn |
| Mar 31, 2025 | 32.73 Mn |
| Dec 31, 2024 | 52.79 Mn |
| Sep 30, 2024 | 17.80 Mn |
| Jun 30, 2024 | 23.91 Mn |
| Mar 31, 2024 | 16.00 Mn |
| Dec 31, 2023 | 51.02 Mn |
| Sep 30, 2023 | 59.20 Mn |
| Jun 30, 2023 | 45.50 Mn |
| Mar 31, 2023 | 19.00 Mn |
| Dec 31, 2022 | 21.61 Mn |
| Sep 30, 2022 | 27.30 Mn |
| Jun 30, 2022 | 30.20 Mn |
| Mar 31, 2022 | 85.50 Mn |
| Dec 31, 2021 | 154.01 Mn |
| Sep 30, 2021 | 19.68 Mn |
| Jun 30, 2021 | 67.45 Mn |